Real-time enrollment status for this non-small cell lung cancer clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 4:19 AM UTC
| NCT Number | NCT07098338 |
| Recruiting Status | Recruiting |
| Condition | Non-Small Cell Lung Cancer |
| Phase | PHASE2 |
| Target Enrollment | 278 participants |
| Active Locations | 6 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | July 1, 2026 (Jul 1, 2026) |
As of August 28, 2026: Clinical trial NCT07098338 is currently recruiting participants. This phase2 study for non-small cell lung cancer is actively seeking new participants at 6 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07098338 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07098338 was last updated Jul 1, 2026 (July 1, 2026). HelloStudys verifies this status automatically.